These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ARGONAUT-III and -V: susceptibility of carbapenem-resistant Jacobs MR; Abdelhamed AM; Good CE; Mack AR; Bethel CR; Marshall S; Hujer AM; Hujer KM; Patel R; van Duin D; Fowler VG; Rhoads DD; Six DA; Moeck G; Uehara T; Papp-Wallace KM; Bonomo RA Antimicrob Agents Chemother; 2024 Sep; 68(9):e0075124. PubMed ID: 39133021 [TBL] [Abstract][Full Text] [Related]
6. Analysis of carbapenemases genes of carbapenem-resistant Pourgholi L; Farhadinia H; Hosseindokht M; Ziaee S; Nosrati R; Nosrati M; Boroumand M Iran J Microbiol; 2022 Feb; 14(1):38-46. PubMed ID: 35664723 [TBL] [Abstract][Full Text] [Related]
7. Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Bakthavatchalam YD; Shankar A; Muthuirulandi Sethuvel DP; Asokan K; Kanthan K; Veeraraghavan B Future Sci OA; 2020 Feb; 6(4):FSO461. PubMed ID: 32257374 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, and other agents against Liao CH; Lee NY; Tang HJ; Lee SS; Lin CF; Lu PL; Wu JJ; Ko WC; Lee WS; Hsueh PR Infect Drug Resist; 2019; 12():545-552. PubMed ID: 30881060 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens]. Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227 [TBL] [Abstract][Full Text] [Related]
10. Fosfomycin-meropenem synergistic combination against NDM carbapenemase-producing Klebsiella pneumoniae strains. Della Rocca MT; Di Caprio G; Colucci F; Merola F; Panetta V; Cordua E; Greco R New Microbiol; 2023 Sep; 46(3):264-270. PubMed ID: 37747471 [TBL] [Abstract][Full Text] [Related]
11. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199 [TBL] [Abstract][Full Text] [Related]
12. Carbapenemase investigation with rapid phenotypic test (RESIST-4 O.K.N.V) and comparison with PCR in carbapenem-resistant Yaşar-Duman M; Çilli F; Tekintaş Y; Polat F; Hoşgör-Limoncu M Iran J Microbiol; 2022 Jun; 14(3):328-333. PubMed ID: 37124854 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015. Sader HS; Castanheira M; Flamm RK Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria El Hafi B; Rasheed SS; Abou Fayad AG; Araj GF; Matar GM Front Microbiol; 2019; 10():933. PubMed ID: 31114565 [TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains. Erdem F; Abulaila A; Aktas Z; Oncul O Antimicrob Resist Infect Control; 2020 May; 9(1):70. PubMed ID: 32430058 [TBL] [Abstract][Full Text] [Related]
16. An Alliance of Carbapenem-Resistant Soltani E; Hasani A; Rezaee MA; Nahandi MZ; Hasani A; Gholizadeh P Can J Infect Dis Med Microbiol; 2022; 2022():6086979. PubMed ID: 36452942 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of carbapenemase genes among carbapenem-nonsusceptible Castanheira M; Deshpande LM; Mendes RE; Doyle TB; Sader HS JAC Antimicrob Resist; 2022 Oct; 4(5):dlac098. PubMed ID: 36196444 [TBL] [Abstract][Full Text] [Related]